Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Horev

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Scientific Reports|October 26, 2013
Molecular imaging of tumors and metastases using chemical exchange saturation transfer (CEST) MRIMichal Rivlin, Judith Horev, Ilan Tsarfaty, et al.
Oncoscience|January 17, 2015
Interplay Between HGF/SF-Met-Ras Signaling, Tumor Metabolism and Blood Flow as a Potential Target for Breast Cancer TherapySari Natan, Galia Tsarfaty, Judith Horev, et al.
Cancer Research|September 5, 2006
Mimp, a mitochondrial carrier homologue, inhibits Met-HGF/SF-induced scattering and tumorigenicity by altering Met-HGF/SF signaling pathwaysRaya Leibowitz-Amit, Galia Tsarfaty, Yamit Abargil, et al.
Plos One|November 19, 2011
Cell motility dynamics: a novel segmentation algorithm to quantify multi-cellular bright field microscopy imagesAssaf Zaritsky, Sari Natan, Judith Horev, et al.
Plos One|July 1, 2016
Mimp/Mtch2, an Obesity Susceptibility Gene, Induces Alteration of Fatty Acid Metabolism in Transgenic MiceYamit Bar-Lev, Sharon Moshitch-Moshkovitz, Galia Tsarfaty, et al.
Plos One|October 11, 2012
Met kinetic signature derived from the response to HGF/SF in a cellular model predicts breast cancer patient survivalGideon Y Stein, Nir Yosef, Hadar Reichman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathwayZohar Tiran, Anat Oren, Chen Hermesh, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Scientific Reports|October 26, 2013
Molecular imaging of tumors and metastases using chemical exchange saturation transfer (CEST) MRIMichal Rivlin, Judith Horev, Ilan Tsarfaty, et al.
Oncoscience|January 17, 2015
Interplay Between HGF/SF-Met-Ras Signaling, Tumor Metabolism and Blood Flow as a Potential Target for Breast Cancer TherapySari Natan, Galia Tsarfaty, Judith Horev, et al.
Cancer Research|September 5, 2006
Mimp, a mitochondrial carrier homologue, inhibits Met-HGF/SF-induced scattering and tumorigenicity by altering Met-HGF/SF signaling pathwaysRaya Leibowitz-Amit, Galia Tsarfaty, Yamit Abargil, et al.
Plos One|November 19, 2011
Cell motility dynamics: a novel segmentation algorithm to quantify multi-cellular bright field microscopy imagesAssaf Zaritsky, Sari Natan, Judith Horev, et al.
Plos One|July 1, 2016
Mimp/Mtch2, an Obesity Susceptibility Gene, Induces Alteration of Fatty Acid Metabolism in Transgenic MiceYamit Bar-Lev, Sharon Moshitch-Moshkovitz, Galia Tsarfaty, et al.
Plos One|October 11, 2012
Met kinetic signature derived from the response to HGF/SF in a cellular model predicts breast cancer patient survivalGideon Y Stein, Nir Yosef, Hadar Reichman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathwayZohar Tiran, Anat Oren, Chen Hermesh, et al.
Pageof 1